Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...
The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...
By Mariam Sunny March 3 (Reuters) - Strive Pharmacy said on Tuesday it has no plans to resume sales of a compounded version of Novo Nordisk's oral semaglutide, pushing back on an earlier media report ...
Compounded NAD+ Telehealth Access, FDA Classification, Pharmacy Sourcing Standards, Prescription Requirements, and Consumer ...
BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy offers low-dose naltrexone, ketamine, and other alternative treatment options for the growing mental health crisis in the United States.
If you’ve received medication through popular telemedicine companies like Hims & Hers Health, you’re probably familiar with drug compounding. That’s the process of creating customized medicine for a ...
AUSTIN, Texas — “The reason I contacted you is that I wanted you to know that compounding pharmacy, good community compounding pharmacy still exists,” said Daniel Dougharty, business developer for ...
BERKELEY, Calif.--(BUSINESS WIRE)--CIO Bulletin, an interactive leadership platform, has named Valor Compounding Pharmacy one of the 50 Best Companies to Watch. The distinction comes hand in hand with ...
Compounding pharmacies can offer a life-saving medicine to patients who may not be able to take standard medication, but the industry is in the midst of challenges because of rules and regulations ...
ALEXANDRIA, VA, UNITED STATES, January 26, 2026 / EINPresswire.com / — The Alliance for Pharmacy Compounding (APC) today announced a new, exclusive accreditation partnership with Coalition for ...
The FDA’s approval of the drug Aduhelm as a treatment for Alzheimer’s disease — despite the recommendation of its own advisory committee against approval — came as a surprise to many. But to me, that ...